Cashman Neil — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Cashman Neil has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Neil Cashman is the Chief Scientific Officer and a Director at ProMIS Neurosciences Inc., a biotechnology company focused on developing antibody therapeutics for neurodegenerative diseases. He has been involved in the company's efforts to target toxic misfolded proteins associated with conditions like Alzheimer's disease.

Board memberships

• ProMIS Neurosciences Inc.

Awards & honors

• Chief Scientific Officer at ProMIS Neurosciences
• Director at ProMIS Neurosciences

Recent Transactions

Companies — Last 90 Days

• ProMIS Neurosciences Inc. (PMN) — 1 filings, last 2026-05-22

Frequently Asked Questions

Who is Cashman Neil?

Neil Cashman is the Chief Scientific Officer and a Director at ProMIS Neurosciences Inc., a biotechnology company focused on developing antibody therapeutics for neurodegenerative diseases. He has been involved in the company's efforts to target toxic misfolded proteins associated with conditions like Alzheimer's disease.…

How many SEC Form 4 filings has Cashman Neil submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Cashman Neil's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week